Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
System1 A | SST | Jan 16, 2025 | 0.62 | -6.98 |
T Stamp A | IDAI | Jan 16, 2025 | 4.41 | -1.78 |
T-Mobile US | TMUS | Jan 16, 2025 | 215.75 | +0.72 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Jan 16, 2025 | 42.39 | -0.56 |
T. Rowe Price Dividend Growth ETF | TDVG | Jan 16, 2025 | 40.41 | +0.55 |
T. Rowe Price Equity Income ETF | TEQI | Jan 16, 2025 | 41.70 | +0.55 |
T. Rowe Price Group | TROW | Jan 16, 2025 | 112.13 | -1.05 |
T. Rowe Price Growth Stock ETF | TGRW | Jan 16, 2025 | 39.71 | -0.91 |
T2 Biosystems | TTOO | Jan 16, 2025 | 0.26 | -7.14 |
Taboola.com | TBLA | Jan 16, 2025 | 3.55 | -0.84 |
Tactile Systems Technology | TCMD | Jan 16, 2025 | 17.43 | -0.34 |
Taitron Components A | TAIT | Jan 16, 2025 | 2.60 | +0.33 |
Taiwan Fund | TWN | Jan 16, 2025 | 37.86 | -0.55 |
Taiwan Index MSCI Ishares | EWT | Jan 16, 2025 | 51.98 | +0.87 |
Taiwan Semiconductor Manufacturing ADR | TSM | Jan 16, 2025 | 214.79 | +3.86 |
Take-Two Interactive Software | TTWO | Jan 16, 2025 | 183.37 | +1.13 |
Takeda Pharmaceutical ADR | TAK | Jan 16, 2025 | 13.05 | -0.38 |
TAL Education Group ADR | TAL | Jan 16, 2025 | 9.68 | +0.83 |
Talen Energy | TLN | Jan 16, 2025 | 234.16 | +3.43 |
Talkspace | TALK | Jan 16, 2025 | 3.04 | +3.40 |
Talos Energy | TALO | Jan 16, 2025 | 11.01 | +2.13 |
Talphera | TLPH | Jan 16, 2025 | 0.62 | +6.80 |
Tamboran Resources | TBN | Jan 16, 2025 | 21.64 | +0.89 |
Tandem Diabetes Care | TNDM | Jan 16, 2025 | 37.53 | +4.40 |
Tanger | SKT | Jan 16, 2025 | 32.85 | -0.30 |
Tango Therapeutics | TNGX | Jan 16, 2025 | 2.78 | +1.09 |
Tantech | TANH | Jan 16, 2025 | 0.17 | +8.19 |
Taoping | TAOP | Jan 16, 2025 | 0.32 | +1.55 |
Tapestry | TPR | Jan 16, 2025 | 69.63 | +2.93 |
Targa Resources | TRGP | Jan 16, 2025 | 212.95 | +3.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.